Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2000 1
2002 2
2003 3
2009 2
2011 1
2012 2
2013 3
2014 1
2015 4
2016 3
2017 5
2018 2
2019 4
2020 5
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Gnant M, Pfeiler G, Steger GG, Egle D, Greil R, Fitzal F, Wette V, Balic M, Haslbauer F, Melbinger-Zeinitzer E, Bjelic-Radisic V, Jakesz R, Marth C, Sevelda P, Mlineritsch B, Exner R, Fesl C, Frantal S, Singer CF; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. Among authors: exner r. Lancet Oncol. 2019 Mar;20(3):339-351. doi: 10.1016/S1470-2045(18)30862-3. Epub 2019 Feb 19. Lancet Oncol. 2019. PMID: 30795951 Clinical Trial.
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. Among authors: exner r. Lancet. 2015 Aug 1;386(9992):433-43. doi: 10.1016/S0140-6736(15)60995-3. Epub 2015 May 31. Lancet. 2015. PMID: 26040499 Clinical Trial.
Local therapies for breast cancer.
Exner R. Exner R. Memo. 2017;10(3):181-184. doi: 10.1007/s12254-017-0336-2. Epub 2017 Jun 7. Memo. 2017. PMID: 28989544 Free PMC article. Review.
Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer.
Strobl S, Wimmer K, Exner R, Devyatko Y, Bolliger M, Fitzal F, Gnant M. Strobl S, et al. Among authors: exner r. Curr Treat Options Oncol. 2018 Mar 12;19(4):18. doi: 10.1007/s11864-018-0535-z. Curr Treat Options Oncol. 2018. PMID: 29527635 Review.
Adjuvant Bisphosphonates and Breast Cancer Survival.
Strobl S, Korkmaz B, Devyatko Y, Schuetz M, Exner R, Dubsky PC, Jakesz R, Gnant M. Strobl S, et al. Among authors: exner r. Annu Rev Med. 2016;67:1-10. doi: 10.1146/annurev-med-053014-103600. Epub 2015 Aug 28. Annu Rev Med. 2016. PMID: 26332000 Review.
Therapeutic potential of glutathione.
Exner R, Wessner B, Manhart N, Roth E. Exner R, et al. Wien Klin Wochenschr. 2000 Jul 28;112(14):610-6. Wien Klin Wochenschr. 2000. PMID: 11008322 Review.
Rational design of an argon-binding superelectrophilic anion.
Mayer M, van Lessen V, Rohdenburg M, Hou GL, Yang Z, Exner RM, Aprà E, Azov VA, Grabowsky S, Xantheas SS, Asmis KR, Wang XB, Jenne C, Warneke J. Mayer M, et al. Among authors: exner rm. Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8167-8172. doi: 10.1073/pnas.1820812116. Epub 2019 Apr 5. Proc Natl Acad Sci U S A. 2019. PMID: 30952786 Free PMC article.
Synthesis and Derivatization of 1,1-[18 F]Difluorinated Alkenes.
Frost AB, Brambilla M, Exner RM, Tredwell M. Frost AB, et al. Among authors: exner rm. Angew Chem Int Ed Engl. 2019 Jan 8;58(2):472-476. doi: 10.1002/anie.201810413. Epub 2018 Dec 6. Angew Chem Int Ed Engl. 2019. PMID: 30452114
Optimal duration of adjuvant endocrine therapy: how to apply the newest data.
Wimmer K, Strobl S, Bolliger M, Devyatko Y, Korkmaz B, Exner R, Fitzal F, Gnant M. Wimmer K, et al. Among authors: exner r. Ther Adv Med Oncol. 2017 Nov;9(11):679-692. doi: 10.1177/1758834017732966. Epub 2017 Oct 27. Ther Adv Med Oncol. 2017. PMID: 29344105 Free PMC article. Review.
44 results